Job Title

Lab Inventory Control Analyst

Requisition

JR000014093 Lab Inventory Control Analyst (Open)

Location

Hobart, NY (Pharma) - USA036

Additional Locations

Hobart, NY

Job Description

Performs daily lab sample login, reconciliation and/or transfer of waste from generation areas to vault/cages.

Seals drums for destruction and manages the lab waste system

Performs data entry in an Application (Such as BPCS or ELN) on waste transactions to remove testing or destruction material from inventory of laboratory systems and processes.

Ensures a complete and accurate inventory on tested samples and/or waste and other controlled substances as required by DEA regulations

Closely monitors and/or verifies weights on tamper evident bags and reconciles any discrepancies.

Works with other site departments if needed, such as the DEA Compliance group

Other duties as assigned.

Minimum Requirements

Education:

High School Diploma or equivalent required.

Associate degree in science related with equivalent combination of education, experience, and competencies preferred.

Experience:

Classroom or previous work experience in a science related field

Preferred Skills/Qualifications:

Self-motivated; able to work with various departments internally and contacts outside of the organization.

BPCS experience.

Must take initiative and act without direction when appropriate.

Must have Microsoft software experience (ie Outlook, Word, Excel, PowerPoint etc) and computer skills.

2 years of experience in a pharmaceutical environment or other industry regulated by a federal agency.

Previous experience with DEA recordkeeping a plus.

Excellent oral and written communication skills.

Detail oriented.

Organizational skills.

Compensation range: $40,000.00 - $46,000.00

1st shift + eligible for sign-on bonus

Mallinckrodt is a global specialty p harmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and central nervous system drugs. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines; its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Mallinckrodt Pharmaceuticals (“the Company”) maintains a continuing policy of non-discrimination in employment. The Company is an equal opportunity employer and complies with all applicable laws prohibiting discrimination based upon age, ancestry, color, religious creed (including religious dress and grooming practices), disability (mental and physical), marital status, medical condition, genetic information, military and veteran status, national origin (including language use restrictions), political activities or affiliation, race, sex (including pregnancy, child birth, breastfeeding and medical conditions related to pregnancy, child birth or breastfeeding), gender, gender identity and gender expression, sexual orientation, as well as any other category protected by law. Furthermore, it is our policy to provide equal opportunity to individuals with disabilities and protected veterans in all phases of the employment process and in compliance with applicable federal, state, and local laws and regulations on every location in which the company has facilities. This policy of non-discrimination shall include, but not be limited to, the following employment decisions and practices: recruiting, hiring; promotions; demotions or transfers; layoffs; recalls; terminations; rates of pay or other forms of compensation; selection for training, including apprenticeship; and recruitment or recruitment advertising.

Mallinckrodt Pharmaceuticals is required to report certain payments or transfers of value (such as expense reimbursement, meals, transportation) made to U.S.-licensed healthcare professionals in compliance with the federal Physician Payment Sunshine Act (i.e. Open Payments) and certain state laws.